LYRA (Lyra Therapeutics, Inc.) Utang jangka cendhak marang modal
This visual market valuation helps analyze the resilience of Lyra Therapeutics, Inc. (LYRA), whose competitive moat is based on nasal implant patents and lobbyist support under strict FDA oversight. The indicator stands at 0.00. Lyra Therapeutics, Inc. (LYRA) is implementing eco-friendly synthesis and zero-waste chemical disposal. The business relies on an open niche for non-surgical rhinosinusitis treatment, ensuring stable demand from physicians.
Rincian analitis perusahaan Lyra Therapeutics, Inc.
- kuotasi lan prakiraan analis:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal Lyra Therapeutics, Inc.|LYRA - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Lyra Therapeutics|LYRA - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Lyra Therapeutics Inc.|LYRA - Utang jangka dawa|Kewajiban jangka cendhak perusahaan Lyra Therapeutics|Rasio cepet lyratherapeutics.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
Pambiji fundamental:LYRA Lyra Therapeutics, Inc
This ratio determines the share of short-term liabilities within the equity structure, reflecting the issuer's level of dependence on operational debt financing. By analyzing the trend of short-term debt to equity, an investor can assess the financial stability of Lyra Therapeutics, Inc. (LYRA) while scaling its drug delivery platform and preparing for the mass market launch of ENT products.
Pesaing Lyra Therapeutics, Inc. (LYRA)
Utang jangka cendhak marang modal HLN|KVUE (Kenvue Health) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal VRNA (Verona Pharma plc)|Utang jangka cendhak marang modal jyongbio.com MENS|LGND - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal glpg.com|Rasio utang jangka cendhak marang ekuitas ANIP (ANI Pharmaceuticals, Inc.)|MNKD (MannKind Corp) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Amphastar AMPH|Pacira Corp (PCRX) - Kewajiban jangka cendhak marang modal|SPRY: Rasio utang jangka cendhak marang ekuitas|theravance.com - Rasio silihan jangka cendhak marang modal|AQST: Utang jangka cendhak marang modal|scPharmaceuticals - Rasio tanggungan utang jangka cendhak marang modal|TECX (Tectonic Therapeutic Inc.) - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Tonix Pharmaceuticals Holding TNXP|Utang jangka cendhak marang ekuitas China SXT Pharmaceuticals (SXTC)|EPRX (eupraxiapharma.com) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas BioHarvest Sciences Inc. BHST|Invizyne Technologies - Utang jangka cendhak marang ekuitas|ORMP: Rasio utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal Entera Bio Ltd.|MindWalk Holdings (HYFT) - Utang jangka cendhak marang ekuitas|abvcpharma.com - Rasio tanggungan utang jangka cendhak marang modal|CPIX (Cumberland Pharmaceuticals Inc.) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal Quantum BioPharma Ltd.|Rasio utang jangka cendhak marang ekuitas FGEN (FibroGen Corp)|TELO (Telomir Pharmaceuticals Corp) - Rasio tanggungan utang jangka cendhak marang modal|Rani Therapeutics Holdings, Inc. - Rasio utang jangka cendhak marang ekuitas|Rasio silihan jangka cendhak marang modal SNYR (Synergy CHC Corp.)|Rallybio Corp. - Utang jangka cendhak marang modal|Rasio tanggungan utang jangka cendhak marang modal LEXX (Lexaria Bioscience)|PULM: Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Pheton Holdings (PTHL)|Utang jangka cendhak marang ekuitas Aptorum Group Ltd|IBO: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal TNFA|Utang jangka cendhak marang modal cbdmd.com (YCBD)|Utang jangka cendhak marang ekuitas PainReform Limited PRFX|CYTO (Altamira Therapeutics Ltd) - Kewajiban jangka cendhak marang ekuitas|Lipella Pharmaceuticals - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal optinose.com|PIRS (Pieris Pharmaceuticals, Inc.) - Rasio utang jangka cendhak marang ekuitas|Procaps Group (PROC) - Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas PTPI|QLI (Qilian International Corp) - Rasio silihan jangka cendhak marang modal|Utang jangka cendhak marang modal SLRN|Koefisien utang jangka cendhak marang modal tffpharma.com